| US12042481B2 | 23 July 2024 | Grant | US17200719 | Use of (1R,5S)-(+)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters | Otsuka America Pharmaceutical Inc |
|---|
| US12042302B2 | 23 July 2024 | Grant | US17326435 | Enhanced ingestible event indicators and methods for making and using the same | Otsuka Pharmaceutical Co Ltd |
|---|
| US12037345B2 | 16 July 2024 | Grant | US17262341 | Heterobicyclic compounds for inhibiting the activity of shp2 | Taiho Pharmaceutical Co Ltd; Otsuka Pharmaceutical Co Ltd |
|---|
| US12036558B2 | 16 July 2024 | Grant | US16963428 | Temperature adjustment stage | Otsuka Pharmaceutical Co Ltd |
|---|
| US12036215B2 | 16 July 2024 | Grant | US17059376 | Antitumor agent and method for tumor therapy | Taiho Pharmaceutical Co Ltd |
|---|